bluebird bio, Inc. is a leading biotechnology company based in Somerville, MA, dedicated to developing curative gene therapies for patients and their families. With a focus on diseases such as Beta-Thalassemia, Cerebral Adrenoleukodystrophy, and Sickle Cell Disease, bluebird bio is committed to providing innovative solutions through their one-time gene therapy treatments. Their proprietary lentiviral vector gene therapies aim to deliver functional copies of genes to a patient's own cells, setting a new standard in the field of gene therapy. For over a decade, bluebird bio has been at the forefront of gene therapy advancements, leveraging the largest and deepest ex-vivo gene therapy data set in the world. Their approach involves collaboration, learning from the realities of others, and engaging in conversations that shape their actions and intentions. By pursuing a different approach to treating diseases and building platforms with broad therapeutic potential, bluebird bio is dedicated to delivering more "bluebird days" for patients and their families.Generated from the website

Shawndre Bossi

Alpha Management Corp

1200 Realty